Global Gastroparesis Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Idiopathic, Diabetic, Post-Surgical, and Others.

By Drug Class;

Prokinetic Drugs, Antiemetics, Antidepressants, and Others.

By End User;

Hospitals and Surgical Centers, Ambulatory Care Centers, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn963435062 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Gastroparesis Treatment Market (USD Million), 2021 - 2031

In the year 2024, the Global Gastroparesis Treatment Market was valued at USD 5,464.88 million. The size of this market is expected to increase to USD 7,000.02 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.6%.

The global gastroparesis treatment market encompasses a diverse range of therapeutic interventions aimed at managing the symptoms and underlying causes of gastroparesis, a chronic digestive disorder characterized by delayed stomach emptying. This condition can lead to a variety of debilitating symptoms such as nausea, vomiting, abdominal pain, bloating, and early satiety, significantly impacting patients' quality of life. The market is driven by the increasing prevalence of gastroparesis, rising awareness among healthcare professionals and patients, and advancements in treatment modalities.

One of the key drivers of the global gastroparesis treatment market is the growing prevalence of gastroparesis worldwide, attributed to factors such as the rising incidence of diabetes, a leading cause of secondary gastroparesis, and changes in lifestyle and dietary habits. As the prevalence of risk factors associated with gastroparesis continues to rise, there is a corresponding increase in the number of patients seeking medical intervention for symptom management and disease progression. This trend has led to heightened interest and investment in the development of novel therapeutics and treatment approaches tailored to the diverse needs of gastroparesis patients.

Advancements in treatment modalities are shaping the landscape of the global gastroparesis treatment market, offering patients a variety of options to alleviate symptoms and improve gastric motility. Pharmacological interventions such as prokinetic agents, antiemetics, and symptom-relieving medications form the cornerstone of gastroparesis management, providing relief from nausea, vomiting, and other gastrointestinal symptoms. In addition to pharmacotherapy, non-pharmacological approaches such as dietary modifications, lifestyle changes, enteral nutrition, and gastric electrical stimulation (GES) therapy are increasingly utilized to address the multifactorial nature of gastroparesis and optimize patient outcomes. Moreover, ongoing research efforts focused on understanding the pathophysiology of gastroparesis and identifying novel therapeutic targets hold promise for further advancing treatment options and enhancing the standard of care for patients worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Drug Class
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Gastroparesis Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Diabetes
        2. Growing Demand for Minimally Invasive Procedures
        3. Expanding Pipeline of Novel Therapies
        4. Rising Awareness among Healthcare Professionals
      2. Restraints
        1. High Cost of Neurostimulation Devices
        2. Challenges in Diagnosis and Patient Management
        3. Adverse Effects Associated with Treatment
        4. Stringent Regulatory Approval Process
      3. Opportunities
        1. Expansion into Emerging Markets
        2. Integration of Digital Health Solutions
        3. Collaboration for Clinical Trials
        4. Patient Education and Support Programs
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Gastroparesis Treatment Market, By Type, 2021 - 2031 (USD Million)
      1. Idiopathic
      2. Diabetic
      3. Post-Surgical
      4. Others
    2. Global Gastroparesis Treatment Market, By Drug Class, 2021 - 2031 (USD Million)
      1. Prokinetic Drugs
      2. Antiemetics
      3. Antidepressants
      4. Others
    3. Global Gastroparesis Treatment Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals and Surgical Centers
      2. Ambulatory Care Centers
      3. Others
    4. Global Gastroparesis Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic
      2. Kimberly-Clark Corporation
      3. Abbott Laboratories
      4. Salix Pharmaceuticals
      5. Boston Scientific Corporation
      6. Rhythm Pharmaceuticals
      7. Cardinal Health
      8. Alfa Wassermann SPA
  7. Analyst Views
  8. Future Outlook of the Market